Cargando…
Serum midkine as a surrogate biomarker for metastatic prediction in differentiated thyroid cancer patients with positive thyroglobulin antibody
Serum thyroglobulin (Tg) is the main post-operative tumor biomarker for patients with differentiated thyroid cancer (DTC). However, the presence of thyroglobulin antibodies (TgAb) can interfere with Tg level and invalidate the test. In this study, we aimed to investigate the predicative value of mid...
Autores principales: | Jia, Qiang, Meng, Zhaowei, Xu, Ke, He, Xianghui, Tan, Jian, Zhang, Guizhi, Li, Xue, Liu, Na, Hu, Tianpeng, Zhou, Pingping, Wang, Sen, Upadhyaya, Arun, Liu, Xiaoxia, Wang, Huiying, Zhang, Chunmei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378906/ https://www.ncbi.nlm.nih.gov/pubmed/28240744 http://dx.doi.org/10.1038/srep43516 |
Ejemplares similares
-
Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer
por: Upadhyaya, Arun, et al.
Publicado: (2017) -
Changes of serum midkine as a dynamic prognostic factor to monitor disease status in papillary thyroid cancer
por: Li, Ning, et al.
Publicado: (2018) -
Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma
por: Wang, Congcong, et al.
Publicado: (2021) -
Multiple-factor analysis of the first radioactive iodine therapy in post-operative patients with differentiated thyroid cancer for achieving a disease-free status
por: Liu, Na, et al.
Publicado: (2016) -
Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer
por: Hu, Tianpeng, et al.
Publicado: (2016)